376 related articles for article (PubMed ID: 28177494)
1. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.
Renfro LA; Sargent DJ
Ann Oncol; 2017 Jan; 28(1):34-43. PubMed ID: 28177494
[TBL] [Abstract][Full Text] [Related]
2. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
3. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
4. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
[TBL] [Abstract][Full Text] [Related]
6. Precision oncology: A new era of cancer clinical trials.
Renfro LA; An MW; Mandrekar SJ
Cancer Lett; 2017 Feb; 387():121-126. PubMed ID: 26987624
[TBL] [Abstract][Full Text] [Related]
7. Challenges with Novel Clinical Trial Designs: Master Protocols.
Cecchini M; Rubin EH; Blumenthal GM; Ayalew K; Burris HA; Russell-Einhorn M; Dillon H; Lyerly HK; Reaman GH; Boerner S; LoRusso PM
Clin Cancer Res; 2019 Apr; 25(7):2049-2057. PubMed ID: 30696689
[TBL] [Abstract][Full Text] [Related]
8. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
[No Abstract] [Full Text] [Related]
9. Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker.
Beckman RA; Antonijevic Z; Kalamegham R; Chen C
Clin Pharmacol Ther; 2016 Dec; 100(6):617-625. PubMed ID: 27509351
[TBL] [Abstract][Full Text] [Related]
10. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial designs incorporating predictive biomarkers.
Renfro LA; Mallick H; An MW; Sargent DJ; Mandrekar SJ
Cancer Treat Rev; 2016 Feb; 43():74-82. PubMed ID: 26827695
[TBL] [Abstract][Full Text] [Related]
12. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
[TBL] [Abstract][Full Text] [Related]
13. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
Ravi R; Kesari HV
Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
[TBL] [Abstract][Full Text] [Related]
14. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
Zardavas D; Piccart-Gebhart M
Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
[TBL] [Abstract][Full Text] [Related]
15. Revolutionizing cancer drug development: Harnessing the potential of basket trials.
Subbiah V; Burris HA; Kurzrock R
Cancer; 2024 Jan; 130(2):186-200. PubMed ID: 37934000
[TBL] [Abstract][Full Text] [Related]
16. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
Farwell MD; Clark AS; Mankoff DA
JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
[No Abstract] [Full Text] [Related]
17. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
18. Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials.
Collignon O; Gartner C; Haidich AB; James Hemmings R; Hofner B; Pétavy F; Posch M; Rantell K; Roes K; Schiel A
Clin Pharmacol Ther; 2020 May; 107(5):1059-1067. PubMed ID: 32017052
[TBL] [Abstract][Full Text] [Related]
19. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
[TBL] [Abstract][Full Text] [Related]
20. Umbrella and basket trials in oncology: ethical challenges.
Strzebonska K; Waligora M
BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
